Advertisement

Biolase wins a nod from the FDA to expand its soft-tissue laser to 19 different markets.

Biolase logo

Biolase (NSDQ:BIOL) won FDA approval for the use of its 940nm Diolase 10 laser in a range of different markets. The federal watchdog agency also cleared 80 new procedures for the device.

The Irvine, Ca-based dental laser company said it can now sell into more than 20 new markets, including ear, nose and throat, arthroscopy, dermatology, plastic surgery and ophthalmology.

Advertisement
Advertisement